PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Worldwide Research and Development, Pfizer Inc, La Jolla, CA, 92121, USA.\', \'Worldwide Research and Development, Pfizer Inc, La Jolla, CA, 92121, USA. rhys.jones@pfizer.com.\', \'Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA.\', \'Worldwide Research and Development, Pfizer Inc, Groton, CT, 06340, USA.\', \'Calibr, a division of The Scripps Research Institute, La Jolla, CA, 92037, USA.\', \'Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.\', \'Department of Microbiology and Immunology University of Maryland School of Medicine, Baltimore, MD, 21201, USA.\', \'Worldwide Research and Development, Pfizer Inc., Collegeville, PA, 19426, USA.\', \'Department of Biochemistry, Purdue University, West Lafayette, IN, 47907, USA.\', \'Worldwide Research and Development, Pfizer Inc, Sandwich, CT13 9ND, UK.\', \'Worldwide Research and Development, Pfizer Inc, Cambridge, MA, 02139, USA.\', \'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, 85721, USA.\', \'Worldwide Research and Development, Pfizer Inc., Pearl River, NY, 10965, USA.\', \'Worldwide Research and Development, Pfizer Inc, Lake Forest, IL, 60045, USA.\', \'UC San Diego Division of Infectious Diseases and Global Public Health, UC San Diego School of Medicine, La Jolla, CA, 92093, USA.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-26239-2
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34663813
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all